AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.360
+0.040 (1.72%)
Aug 7, 2026, 4:00 PM EDT - Market closed
AC Immune Market Cap
AC Immune has a market cap or net worth of $234.65 million as of August 7, 2026. Its market cap has increased by 7.44% in one year.
Market Cap
234.65M
Enterprise Value
146.46M
1-Year Change
7.44%
Ranking
Category
Stock Price
$2.36
ChartMarket Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $234.65M, a decrease of -72.95%. That is a compound annual growth rate of -12.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 240.10M | -24.21% |
| Dec 31, 2025 | 316.80M | 17.51% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
| Sep 23, 2016 | 867.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Entrada Therapeutics | 247.71M |
| Niagen Bioscience | 247.39M |
| Capricor Therapeutics | 236.86M |
| Pyxis Oncology | 236.32M |
| Protara Therapeutics | 231.56M |
| Compugen | 228.29M |
| Galectin Therapeutics | 227.21M |
| Keros Therapeutics | 221.07M |